1-tert-Butyl 2-methyl azepane-1,2-dicarboxylate

Catalog No. :
ACGCSM054
CAS No. :
1352305-12-4
Molecular Formula :
C13H23NO4
Molecular Weight :
257.33

IUPAC Name:1-(tert-butyl) 2-methyl azepane-1,2-dicarboxylate

1-tert-Butyl 2-methyl azepane-1,2-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$134.00Login to see priceIn stockInquiry
250mg95%$223.00Login to see priceIn stockInquiry
500mg95%$371.00Login to see priceIn stockInquiry
1g95%$557.00Login to see priceIn stockInquiry
5g95%$1670.00Login to see priceIn stockInquiry
10g95%$2783.00Login to see priceInquiryInquiry
25g95%$5566.00Login to see priceInquiryInquiry
50g95%$8906.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-tert-Butyl 2-methyl azepane-1,2-dicarboxylate
IUPAC Name1-(tert-butyl) 2-methyl azepane-1,2-dicarboxylate
MDL No.MFCD20921681
Molecular FormulaC13H23NO4
Molecular Weight257.33
SMILESO=C(C1N(C(OC(C)(C)C)=O)CCCCC1)OC
InChI KeySLPFKKMDHRUNRM-UHFFFAOYSA-N
Synonym1-(tert-butyl)2-methylazepane-1,2-dicarboxylate;1H-Azepine-1,2-dicarboxylic acid, hexahydro-, 1-(1,1-dimethylethyl) 2-methyl ester;O1-tert-butyl O2-methyl azepane-1,2-dicarboxylate
CAS No.1352305-12-4

Synthetic Route by SureRoute

1. ACGCSM054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGCSM054 route product structure diagram
    ACGCSM0541352305-12-4 In Stock
Inquiry

2. ACGCSM054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBRHP064 route compound structure diagram
    ACBRHP06434459-10-4 In Stock
  4. Then
  5. ACGCSM054 route product structure diagram
    ACGCSM0541352305-12-4 In Stock
Inquiry

Comments (0)